Recent Quotes
My Watchlist
Indicators
EL&P Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Galapagos NV - American Depositary Shares (NQ:GLPG)

31.32 +0.19 (+0.61%)
Streaming Delayed Price Updated: 1:00 PM EST, Nov 28, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 40,975
Open 31.00
Bid (Size) 29.80 (100)
Ask (Size) 32.50 (300)
Prev. Close 31.13
Today's Range 31.00 - 31.51
52wk Range 22.36 - 37.78
Shares Outstanding 65,897,071
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Why Crown Holdings Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
Adaptimmune Plunges After Announcing Nasdaq Delisting Amidst Compliance Failures and Cost-Cutting Measures
Adaptimmune Therapeutics plc (NASDAQ: ADAP) has sent shockwaves through the biotechnology sector with its announcement on October 20, 2025, of a voluntary delisting of its American Depositary Shares... 
Via MarketMinute
Topics Initial Public Offering Regulatory Compliance Workforce

Performance

YTD
+12.3%
+12.3%
1 Month
+1.3%
+1.3%
3 Month
-0.4%
-0.4%
6 Month
+8.9%
+8.9%
1 Year
+13.3%
+13.3%

More News

Read More
News headline image
Tesla Posts Downbeat Earnings, Joins Community Health Systems, Chipotle Mexican Grill And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗
Via Benzinga
News headline image
Earnings Scheduled For July 23, 2025 ↗
Via Benzinga
News headline image
Earnings Scheduled For April 23, 2025 ↗
Via Benzinga
News headline image
Uncovering Potential: Galapagos's Earnings Preview ↗
Via Benzinga
News headline image
Earnings Scheduled For November 5, 2025 ↗
Via Benzinga
News headline image
These stocks that are showing activity before the opening bell on Tuesday. ↗
Via Chartmill
News headline image
PACCAR Posts Downbeat Earnings, Joins Neuphoria Therapeutics, Citius Pharmaceuticals And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
Via Benzinga
News headline image
Earnings Scheduled For February 12, 2025 ↗
Via Benzinga
News headline image
Get insights into the top gainers and losers of Thursday's pre-market session. ↗
Via Chartmill
News headline image
Why Alphabet Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket ↗
Via Benzinga
News headline image
Galapagos Announces CFO Exit With No Successor Named Yet: Retail’s Disappointed ↗
Via Stocktwits
Topics Earnings
News headline image
Galapagos Unveils 2025 Split To Accelerate Innovation, Sharpen Strategic Focus ↗
Via Benzinga
News headline image
Why Trip.com Group Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket ↗
Via Benzinga
News headline image
Major Investor Says Galapagos Is 'Undervalued,' Plans To Push On Company's 'Performance' And 'Strategic Opportunities' ↗
Via Benzinga
News headline image
Galapagos Surges On An FDA Win For Its Rival To Gilead, Novartis; But There Are Some Caveats ↗
Via Investor's Business Daily
News headline image
Galapagos, XPeng, CorMedix And Other Big Stocks Moving Higher On Monday ↗
Via Benzinga
News headline image
Why MIRA Pharmaceuticals Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket ↗
Via Benzinga
News headline image
FDA Approves Adaptimmune Therapeutics' Engineered Cell Therapy As First For Solid Tumor And New Therapy For Rare Soft Tissue Cancer In Over A Decade ↗
Via Benzinga
News headline image
GLPG Stock Earnings: Galapagos Beats EPS, Beats Revenue for Q2 2024 ↗
Via InvestorPlace
News headline image
GLPG Stock Earnings: Galapagos Beats EPS, Misses Revenue for Q1 2024 ↗
Via InvestorPlace
News headline image
Adaptimmune and Galapagos Sign Clinical Collaboration Agreement with an Option to Exclusively License Adaptimmune's TCR T-cell Therapy Candidate, uza-cel, in Head & Neck Cancer and Potential Future Solid Tumor Indications
Via Newsfile
News headline image
Galapagos Downgraded, Pharma Firm Faces Uphill Battle With Slow Pipeline Progress: Analyst ↗
Via Benzinga

Frequently Asked Questions

Is Galapagos NV - American Depositary Shares publicly traded?
Yes, Galapagos NV - American Depositary Shares is publicly traded.
What exchange does Galapagos NV - American Depositary Shares trade on?
Galapagos NV - American Depositary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Galapagos NV - American Depositary Shares?
The ticker symbol for Galapagos NV - American Depositary Shares is GLPG on the Nasdaq Stock Market
What is the current price of Galapagos NV - American Depositary Shares?
The current price of Galapagos NV - American Depositary Shares is 31.32
When was Galapagos NV - American Depositary Shares last traded?
The last trade of Galapagos NV - American Depositary Shares was at 11/28/25 01:00 PM ET
What is the market capitalization of Galapagos NV - American Depositary Shares?
The market capitalization of Galapagos NV - American Depositary Shares is 2.06B
How many shares of Galapagos NV - American Depositary Shares are outstanding?
Galapagos NV - American Depositary Shares has 2B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.